Last reviewed · How we verify

NCT03590067

Oral Findings in a Group of Egyptian Pediatric Patients at Endstage Renal Disease

Status unknown Last updated 31 July 2019
What this trial tests

trial testing Questionnaire in Kidney Disease, Chronic in 150 participants. Status unknown.

Timeline
1 November 2019
Primary endpoint
1 December 2019
1 January 2020

Quick facts

Lead sponsorCairo University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date1 November 2019
Primary completion1 December 2019
Estimated completion1 January 2020

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 2 to 14, any sex, with Kidney Disease, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In Egypt, the prevalence of end stage renal disease in pediatric population has never been estimated on a national scale. The patients at end stage renal disease encounter oral and dental problems that emphasize regular and careful screening . In Egypt, the prevalence of oral findings is not studied so we conduct this study to study the oral findings among a group of pediatric patients at end stage renal disease either on haemodialysis or after kidney transplantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Kidney Disease, Chronic

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03590067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing